Shlomo A. Koyfman - Concepedia

Author

Shlomo A. Koyfman

Also Known As

David Adelstein, Richard Ross, S Koyfman, S. A. Koyfman, S. Koyfman, S.A. Koyfman, SHLOMO A. KOYFMAN, SHLOMO KOYFMAN, Shivani Nellore, Shlomo A Koyfman

493

Publications

8.1K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Case Western Reserve University Cleveland Clinic Lerner College of Medicine Memorial Sloan Kettering Cancer Center Moffitt Cancer Center

About

Shlomo A. Koyfman is an author at Cleveland Clinic specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	41	3.6K
2	Health Sciences	13	19	2.9K
3	Cell Biology	1	1	13
4	Epidemiology	1	1	49
5	Gastroenterology	1	1	21

Shlomo A. Koyfman

109

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial Maura L. Gillison, Andy Trotti, Jonathan Harris, The Lancet Radiation TherapyMedicineNasopharyngeal CancerNon-inferiority TrialCancer Treatment	2018	1.2K
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study Brian O’Sullivan, Shao Hui Huang, Jie Su, The Lancet Oncology Cancer-associated VirusOropharyngeal Cancer NetworkInternational CollaborationMedicineStaging System	2016	730
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline Shlomo A. Koyfman, Nofisat Ismaila, Doug Crook, Journal of Clinical Oncology	2019	362
Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States Giorgia L. Garrett, Paul D. Blanc, John Boscardin, JAMA Dermatology	2017	292
Comparison and predictors of rash associated with 15 antiepileptic drugs Hiba Arif, Richard Buchsbaum, David Weintraub, Neurology	2007	276
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement David Thomson, David A. Palma, Matthias Gückenberger, International Journal of Radiation OncologyBiologyPhysics	2020	209
Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery Abigail L. Stockham, Andrew L. Tievsky, Shlomo A. Koyfman, Journal of Neuro-Oncology Neuro-oncologyRadiation TherapyMedical ImagingTumor RecurrenceDistinguish Radiation Necrosis	2012	166
Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative Matthew C. Ward, Nadeem Riaz, Jimmy J. Caudell, International Journal of Radiation OncologyBiologyPhysics Health SciencesPatient SelectionMedicineCancer ManagementCancer Registration	2017	156
A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer John A. Vargo, Matthew C. Ward, Jimmy J. Caudell, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologySecond Primary HeadMedicineMulti-institutional ComparisonHead And Neck Cancer	2017	146
A multi‐institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck Bindu V. Manyam, Adam Garsa, R Chin, Cancer	2017	137

Page 1